This investigation studied the effectiveness of methylene blue (MB) for vasoplegia in LVAD recipients and found that clinical outcomes did not improve after LVAD implantation.
You are here:
Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.05.172
Keywords:
Author(s): Amit Saha, MD, Douglas L. Jennings, PharmD, Yuming Ning, PhD, Paul Kurlansky, MD, Andrea N. Miltiades, MD, Jessica L. Spellman, MD, Joseph Sanchez, MD, Melana Yuzefpolskaya, MD, Paolo C. Colombo, MD, Hiroo Takayama, MD, PhD, Yoshifumi Naka, MD, PhD, and Koji Takeda, MD, PhD
